Dermira, inc. (DERM)
CashFlow / TTM
Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14
Cash flows from operating activities
Net loss

-212,225

-221,148

-227,118

-221,540

-205,742

-318,372

-333,006

-303,261

-254,632

-100,968

-90,157

-89,084

-112,852

-103,396

-92,800

-78,399

-53,975

-45,768

-37,371

-31,875

0

0

0

Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization

593

605

590

555

485

417

373

339

287

235

182

123

105

89

75

72

72

70

69

64

0

0

0

Stock-based compensation

29,277

30,514

30,310

29,843

28,192

25,804

23,602

20,703

18,303

15,667

13,024

11,003

9,384

7,980

6,632

5,132

4,677

3,540

2,601

1,643

0

0

0

Amortization of discount for payments related to acquired in-process research and development

-

-

-

4,839

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net (accretion) amortization of premiums on available-for-sale securities

2,528

2,097

1,338

475

-471

-1,381

-2,036

-2,366

-2,551

-2,433

-2,077

-1,879

-1,764

-1,819

-1,969

-2,012

0

0

0

-

-

-

-

Amortization of debt discount and issuance costs

2,183

2,043

1,999

1,872

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Amortization of operating lease right-of-use assets

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Revaluation of convertible preferred stock warrant liability

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

78

0

0

0

Impairment of intangible assets

-

-

-

1,126

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Loss on disposal of assets

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Changes in assets and liabilities:
Trade and other receivables, net

8,943

59,739

8,393

5,672

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Collaboration receivables from a related party

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-

-

-

-

Collaboration receivables

-

-

-

-

-

-

-

-

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Inventory

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Prepaid expenses and other current assets

10,015

15,482

26,365

1,498

199

1,008

-2,701

-6,233

-134

492

2,571

6,838

3,745

3,095

1,598

1,219

975

1,159

1,384

572

0

0

0

Other assets

4,209

-280

426

2,195

1,589

101

185

-485

11

23

36

-90

235

239

264

-395

0

0

0

-

-

-

-

Accounts payable

-1,741

-795

-4,699

823

3,248

3,869

5,285

1,542

3,521

-324

-7,138

4,266

-571

3,093

5,697

3,607

4,417

3,850

4,422

3,209

0

0

0

Accrued liabilities

-7,526

-3,404

-2,283

-2,821

3,947

7,700

12,362

7,573

7,452

-836

-2,579

454

6,906

9,372

8,944

10,395

8,544

4,352

2,366

4,328

0

0

0

Other long-term liabilities

-

-

-

97

349

350

373

423

530

573

585

128

0

0

0

-

-

-

-

-

-

-

-

Lease liabilities

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred revenue

20,110

21,415

29,920

-379

-722

-1,788

-2,774

-3,541

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Deferred taxes

-

-

-

194

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net cash used in operating activities

-215,172

-266,006

-226,933

-213,098

-166,440

-141,881

-133,732

-103,963

-71,636

-60,369

-73,111

-74,111

-89,133

-82,915

-69,348

-48,442

-40,426

-33,294

-28,935

-31,404

0

0

0

Cash flows from investing activities
Purchases of available-for-sale securities

407,780

250,761

314,255

319,940

334,624

370,832

296,084

302,432

283,389

382,992

275,716

252,175

213,368

65,199

68,818

60,276

0

0

0

-

-

-

-

Maturities of available-for-sale securities

369,129

324,773

335,887

363,328

357,303

349,668

316,869

278,580

231,271

187,553

137,660

122,640

101,751

87,489

75,716

57,875

0

0

0

-

-

-

-

Purchase of property and equipment

133

72

596

616

824

810

278

278

697

692

692

753

0

0

0

-

-

-

-

156

0

0

0

Net cash used in investing activities

-68,784

17,940

-34,964

-13,228

-84,145

-101,974

-59,493

-104,130

-52,815

-196,131

-138,748

-130,288

-111,844

22,036

6,600

-2,603

-114,976

-113,355

-107,611

-109,480

0

0

0

Net proceeds from issuance of common stock in connection with equity financing

0

0

0

-

-

-

-

181,538

179,449

180,729

318,362

135,907

137,475

240,265

104,093

104,047

224,834

120,763

120,313

120,273

0

0

0

Payments for debt issuance cost

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net proceeds from issuance of common stock in connection with equity awards

2,099

2,220

1,972

2,146

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net cash provided by financing activities

213,737

174,917

175,024

35,381

2,231

2,155

280,177

462,523

462,426

463,827

321,405

138,950

136,357

239,147

102,975

102,929

224,833

169,588

174,138

174,098

0

0

0

Net decrease in cash and cash equivalents and restricted cash

-70,219

-73,149

-86,873

-190,945

-248,354

-241,700

86,952

254,430

337,975

207,327

109,546

-65,449

-64,620

178,268

40,227

51,884

69,431

22,939

37,592

33,214

0

0

0

Supplemental disclosure of noncash investing activities